Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy

Clinical and Experimental Immunology

Volumn 174, Issue 1, 2013, Pages 152-160

  Liu, L L ^a   Liu, N ^a   Chen, Y ^a   Wang, L N ^a   Jiang, Y ^a   Wang, J ^a   Li, X L ^a   Yao, L ^a   Fan, Q L ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Complement; IgA nephropathy; MBL; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MANNOSE BINDING LECTIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SERUM ALBUMIN;

ADULT; ARTICLE; ATROPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; STAINING;

BIOMARKER; COMPLEMENT; IGA NEPHROPATHY; MBL; PROGNOSIS;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REMISSION INDUCTION; YOUNG ADULT;

EID: 84883647615     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12154     Document Type: Article

References (26)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24:179-196.
2. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347:738-748.
3. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8:199-207.
4. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton) 2004; 9:177-185.
5. Giannakakis K, Feriozzi S, Perez M, Faraggiana T, Muda AO. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J Am Soc Nephrol 2007; 18:3139-3146.
6. Monteiro RC, Moura IC, Launay P etal. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002; 8:464-468.
7. Hiemstra PS, Biewenga J, Gorter A etal. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol Immunol 1988; 25:527-533.
8. Tomino Y, Sakai H, Miura M, Endoh M, Nomoto Y. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 1982; 49:419-425.
9. Wyattand RJ, Julian BA. Activation of complement in IgA nephropathy. Am J Kidney Dis 1988; 12:437-442.
10. Liu LL, Jiang Y, Wang LN, Liu N. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy. Clin Exp Immunol 2012; 169:148-155.
11. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984; 21:335-340.
12. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11:2395-2403.
13. Roos A, Rastaldi MP, Calvaresi N etal. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17:1724-1734.
14. Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectin of the innate immune defense system. Immunol Today 1994; 15:67-74.
15. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 1998; 13:1984-1990.
16. Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis 2001; 38:1082-1088.
17. D'Amico G, Minetti L, Ponticelli G etal. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 59:363-378.
18. Alamartine E, Sabatier JC, Guerin C etal. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18:12-19.
19. Xie J, Kiryluk K, Wang W etal. Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS ONE 2012; 7:e38904.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 1999; 130:461-470.
21. Lee SM, Rao VM, Franklin WA etal. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13:314-322.
22. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R etal. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76:534-545.
23. Zhang H. IgA nephropathy. In: Wang HY, Li XM, Zhao MH etal., eds. Nephrology, 3rd edn. Beijing: People's Medical Publishing House, 2008:993-1016.
24. Tomiyoshi Y, Sakemi T, Ikeda Y, Ohtsuka Y, Nakamura M, Fujisaki T. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy. Intern Med 2001; 40:862-866.
25. Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol 2004; 8:237-242.
26. Barbour SJ, Reich HN. Risk stratification of patients with IgA nephropathy. Am J Kidney Dis 2012; 59:865-873.